Interim Condensed Consolidated Statements of Income (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Revenues:
Net patient revenues	$ 175,361	$ 182,134	$ 525,211	$ 536,531
Other revenues	14,007	14,930	42,008	44,264
Net operating revenues	189,368	197,064	567,219	580,795
Cost and Expenses:
Salaries, wages and benefits	106,844	106,870	318,028	320,425
Other operating	48,519	54,807	149,271	148,084
Facility rent	9,813	10,000	29,507	29,744
Depreciation and amortization	7,402	7,307	22,168	21,344
Interest	119	136	345	333
Total costs and expenses	172,697	179,120	519,319	519,930
Income Before Non–Operating Income	16,671	17,944	47,900	60,865
Non–Operating Income	6,771	5,140	18,546	14,856
Income Before Income Taxes	23,442	23,084	66,446	75,721
Income Tax Provision	(6,209)	(5,873)	(22,923)	(26,175)
Net Income	17,233	17,211	43,523	49,546
Dividends to Preferred Stockholders	(2,167)	(2,167)	(6,503)	(6,503)
Net Income Available to Common Stockholders	$ 15,066	$ 15,044	$ 37,020	$ 43,043
Earnings Per Common Share:
Basic (in Dollars per share)	$ 1.09	$ 1.09	$ 2.67	$ 3.13
Diluted (in Dollars per share)	$ 1.04	$ 1.05	$ 2.63	$ 3.02
Weighted Average Common Shares Outstanding:
Basic (in Shares)	13,852,403	13,807,995	13,846,022	13,762,084
Diluted (in Shares)	16,605,285	16,444,749	16,578,535	16,404,305